Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Leerink Revelation Partners
AddedMar 19, 2024
UpdatedJun 28, 2026
Leerink Revelation Partners

Leerink Revelation Partners

Operating

Revelation Partners: Healthcare secondary investor providing capital and liquidity solutions.

Location
San Francisco, CA, US
Founded
2013
Firm
Compare
Portfolio
Fundraising
Employees
Website

Leerink Revelation Partners, now known as Revelation Partners, focuses on providing capital and liquidity solutions to healthcare investors, companies, and funds. They invest in rapidly growing healthcare sectors including medical devices, biopharmaceuticals, IT, and healthcare services. Their typical investment rounds range from Series A to Series G, with a significant number of investments in Series B and later stages.

Revelation Partners boasts a notable portfolio with companies such as AcuFocus, Arterys, Aspen Neuroscience, and Omada Health. The firm is led by experienced partners who actively collaborate with management teams to scale businesses. Their investment philosophy centers on creating customized solutions that provide liquidity and align shareholder interests. Unique value-add services include fund manager solutions and shareholder liquidity options, enhancing their appeal to healthcare companies seeking flexible capital.

Leerink Revelation Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments38
Current Portfolio Count29
Total Portfolio Exits2

Top Investment Stages

Series B11 (32.4%)
Series Unknown7 (20.6%)
Series E6 (17.6%)
Series C5 (14.7%)
Series D5 (14.7%)

Stage Mix

Series B 32%Series Unknown 21%Series E 18%Series C 15%Series D 15%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SPR Therapeutics logo

SPR Therapeutics

Vital Connect logo

Vital Connect

Carrum Health logo

Carrum Health

Vedanta Biosciences logo

Vedanta Biosciences

Syapse logo

Syapse

Dren Bio logo

Dren Bio

Aspen Neuroscience logo

Aspen Neuroscience

Iris Telehealth logo

Iris Telehealth

IntelyCare logo

IntelyCare

Gravie logo

Gravie

Omada Health logo

Omada Health

Endeavor Biomedicines logo

Endeavor Biomedicines

Verana Health logo

Verana Health

HotSpot Therapeutics logo

HotSpot Therapeutics

Click Therapeutics logo

Click Therapeutics

Honor logo

Honor

US Fertility logo

US Fertility

Genome Medical logo

Genome Medical

Singular Genomics logo

Singular Genomics

Setpoint Medical logo

Setpoint Medical

Included Health logo

Included Health

NeuroPace logo

NeuroPace

Evidation Health logo

Evidation Health

Arterys logo

Arterys

Injectsense logo

Injectsense

Leerink Revelation Partners - Similar Investment Firms

Leerink Transformation Partners logo

Leerink Transformation Partners

transformcap.com

Revel Partners logo

Revel Partners

revelpartners.com

Revival Healthcare Capital logo

Revival Healthcare Capital

rvlhc.com

Lrvhealth logo

Lrvhealth

lrvhealth.com

Revere Partners logo

Revere Partners

Reformation Partners logo

Reformation Partners

reformation.vc

InnovaHealth Partners logo

InnovaHealth Partners

Amicus Capital Partners logo

Amicus Capital Partners

Galen Partners logo

Galen Partners

galen.com

Flare Capital Partners logo

Flare Capital Partners

flarecapital.com

Regal Healthcare Capital Partners logo

Regal Healthcare Capital Partners

regalhcp.com

Emergent Medical Partners logo

Emergent Medical Partners

emvllp.com

Revolent Capital Solutions logo

Revolent Capital Solutions

Health2047 Capital Partners logo

Health2047 Capital Partners

Signet Healthcare Partners logo

Signet Healthcare Partners

Leerink Revelation Partners - Classification

Also Known As
  • Leerink Revelation Partners LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end